Skip to main content
Equibles

BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in STTK — Shattuck Labs, Inc.

CIK 1107261 HOUSTON, TX
Back to STTK Full portfolio

Position in STTK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$293,562
+$21,573 QoQ
Shares Held
42,300
0.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#61
of 100 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,985,615 across 108 Biotechnology names. STTK ranks #64 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GLUE
Monte Rosa Therapeutics, Inc.
 552,566 $13,372,097
2 INVA
Innoviva, Inc.
 350,253 $7,954,245
3 PBYI
Puma Biotechnology, Inc.
 791,616 $6,420,005
4 RIGL
Rigel Pharmaceuticals Inc
 124,184 $4,858,078
5 EXEL
Exelixis, Inc.
 66,100 $3,596,501
6 CRMD
CorMedix Inc.
 434,132 $3,407,936
7 KROS
Keros Therapeutics, Inc.
 265,017 $2,835,681
8 PTCT
Ptc Therapeutics, Inc.
 22,000 $1,794,540

All Filings in STTK

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $293,562 42,300
2026-03-31 $271,989 42,300
2025-12-31 $154,395 42,300
2025-09-30 $101,097 42,300
2025-06-30 $73,101 92,300
2025-03-31 $35,435 37,300
2024-12-31 $89,903 74,300
2024-09-30 $369,591 105,900
2024-06-30 $143,978 37,300
2024-03-31 $333,462 37,300
2023-12-31 $357,213 50,100
2023-09-30 $146,528 96,400
2023-06-30 $300,768 96,400
2023-03-31 $250,488 85,200
2022-12-31 $195,730 85,100
2022-09-30 $297,270 110,100
2022-06-30 $155,904 38,400